Anda di halaman 1dari 1

Indonesian Journal of Physics and Nuclear Applications

Volume x, Number x, Month year, p. xxx-xxx

EKSPERIMENTAL STUDY: CRACK DETECTION BASED ON EDDY


CURRENT TESTING METHOD FOR BORON NEUTRON CAPTURE
THERAPY (BNCT) NICKEL COLIMATOR APPLICATION
Louis HD Tambunan1*, Prof.Ir.Yohannes Sardjono,APU2, Dr.Eng. I Made Wicaksana
Ekaputra3

1
Sanata Dharma University, Campus III Sanata Dharma University, Yogyakarta, 55281, Indonesia
2
PSTA BATAN, Babarsari street, Yogyakarta 55281, Indonesia

Abstract Knowing the shape of the surface damage or porosity is a major advantage of applying the EddyCurrent (EC) Non-
Destructive Testing (NDT). Neutron collimator is the most important component in a neutron radiography facility set-up,
which defines the neutron beam characteristic at the object plane. The collimator at Boron Neutron Capture Therapy (BNCT)
that under development is made from 99% Nickel material. The collimators are made by centrifugal casting process. The
Collimators are planted to work at high temperatures and continuous working. The purpose of this studies are going to
applying the Eddy Current (EC) Non-Destructive Testing (NDT) BATAN BNCT collimator at Yogyakarta. This test will be
held at the laboratory facilities of Sanata Dharma University Yogyakarta. The results of this research is expecting can be the
benchmark for develop of BNCT technology and material selection.
Keywords BNCT, BATAN YOGYAKARTA, Collimator, NDT, Eddy Current

INTRODUCTION radiotherapy, chemotherapy or their


combination, cancer interventions were
Cancer is one of the world’s most pressing focused on diagnosis and treatment. A focus
problems, with a substantial and increasing on epidemiology, prevention, screening,
burden carried by low and middle-income population medicine or social factors, were
countries (LMIC). For Indigenous people, not part of the early oncology agenda. The
where data are available, cancer is a clinical outcomes of conventional mono-
leading cause of death. Despite recent chemotherapy of cancers are usually far from
advances in these anticancer agents cancer satisfactory due to some issues such as tumor
remains a leading cause of disease-related heterogeneity and resistance to
death worldwide. Only in the United chemotherapeutic drugs. The oncogenic
States, for instance, 1,735,350 new cancer mutations in patients enable replicative
cases and 609,640 cancer-related deaths immortality and activate invasion and
will occur in 2018. Medical intervention in metastasis. Furthermore, mono13
the clinical course of cancer using surgery,

* Louis HD Tambunan. HP.: +62 853-6304-7626; E-mail address: louis26tambunan@gmail.com

Anda mungkin juga menyukai